Amrize financials
$37.71−0.89%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 |
|---|---|---|---|---|---|
| Revenue | $3.49B | $2.18B | $2.84B | $3.67B | $3.22B |
| Gross profit | $993.0M | $208.0M | $760.0M | $1.09B | $941.0M |
| Gross margin | 28.4% | 9.5% | 26.8% | 29.6% | 29.2% |
| Operating income | $708.0M | -$77.0M | $484.0M | $774.0M | $653.0M |
| Net income | $478.0M | -$105.0M | $298.0M | $545.0M | $417.0M |
| Net margin | 13.7% | −4.8% | 10.5% | 14.8% | 13.0% |
| Diluted EPS | $0.86 | $-0.19 | $0.54 | $0.98 | $0.75 |
| EBITDA | $968.0M | -$77.0M | $726.0M | $1.00B | $881.0M |
| Operating cash flow | $421.0M | -$896.0M | $1.80B | $854.0M | $415.0M |
| Free cash flow | $173.0M | -$1.17B | $1.65B | $669.0M | $178.0M |
| Diluted shares | 553.6M | 553.2M | 554.3M | 553.9M | 553.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 |
|---|---|---|---|---|---|
| Cash & equivalents | $729.0M | $1.10B | $1.92B | $826.0M | $601.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $6.00B | $6.05B | $5.27B | $5.81B | $6.20B |
| Total assets | $24.60B | $24.27B | $24.21B | $24.04B | $23.78B |
| Total liabilities | $11.74B | $11.18B | $11.09B | $11.14B | $11.35B |
| Shareholders' equity | $12.86B | $13.09B | $13.12B | $12.90B | $12.43B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology